SECURITY AGREEMENTSecurity Agreement • July 3rd, 2019 • Adhera Therapeutics, Inc. • Pharmaceutical preparations • New York
This SECURITY AGREEMENT (this “Agreement”), dated as of June 28, 2019, among Adhera Therapeutics, Inc., a Delaware corporation (the “Company”), IthenaPharma, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company (“Ithena”), Cequent Pharmaceuticals, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company (“CPI”), and MDRNA Research, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company (“Research” and, collectively with the Company, Ithena and CPI, the “Grantors” and each, individually, a “Grantor”), the various subscribers (each such person (including any subscriber that becomes a party to this Agreement after the date hereof) a “Purchaser” and collectively the “Purchasers”) signatory to those certain Subscription Agreements of substantially like tenor that the Company entered into, and may enter into after the date hereof, with such subscribers pursuant to which the Company shall issue to such subscribers a secured promissory n
